Type 2 Diabetes
Coordinated care can improve prescribing practices of recommended diabetes, CVD therapies
NEW ORLEANS — Implementing a coordinated care intervention in U.S. cardiology clinics led to a fourfold increase in the prescription of three groups of guideline-recommended therapies in adults with type 2 diabetes and atherosclerotic CVD.
Coordinated care can improve prescribing practices of recommended diabetes, CVD therapies
NEW ORLEANS — Implementing a coordinated care intervention in U.S. cardiology clinics led to a fourfold increase in the prescription of three groups of guideline-recommended therapies in adults with type 2 diabetes and atherosclerotic CVD.
Clinical tool demonstrates validity in assessments for COPD, asthma, type 2 diabetes
A recent study in Annals of Family Medicine confirmed the validity and reliability of a clinical tool in assessing burdens of COPD, type 2 diabetes and asthma.
Cognitive behavioral therapy-based intervention reduces diabetes distress for adults
A cognitive behavioral therapy multidisciplinary intervention was associated with a reduction in HbA1c and improvements in diabetes distress for adults with type 1 and type 2 diabetes, according to study findings.
GLP-1/glucagon dual agonist linked to 10% weight loss in half of adults with obesity
About half of adults taking a novel peptide-based GLP-1/glucagon dual receptor agonist in development for the treatment of obesity in nonalcoholic steatohepatitis lost 10% or more body weight at 24 weeks, according to a press release.
Finerenone may give patients with type 2 diabetes, CKD some cardiovascular benefits
Among patients with type 2 diabetes and chronic kidney disease, finerenone treatment may provide cardiovascular benefits, according to data published in the Clinical Journal of the American Society of Nephrology.
SGLT2i treatment correlates with higher risks among patients with CKD, type 2 diabetes
Compared with glucagon-like peptide-1 receptor agonists, patients with chronic kidney disease and type 2 diabetes experienced increased risks when taking SGLT2 inhibitors, according to published data.
Diabetic retinopathy prevalence increases over time in pediatric type 2 diabetes
The prevalence of diabetic retinopathy among children and adolescents with type 2 diabetes greatly increases 5 years after diabetes diagnosis, according to findings from a systematic review and meta-analysis.
Caffeine intake causally associated with lower BMI, type 2 diabetes risk
A high caffeine level in plasma was associated with reduced body fat and a lower risk for type 2 diabetes, according to a two-sample Mendelian randomization study published in BMJ Medicine.
Canagliflozin remains effective for men, women of varying ages with type 2 diabetes, CKD
Among patients with type 2 diabetes and albuminuric chronic kidney disease, canagliflozin reduced kidney and cardiovascular events independent of age or sex, according to data published in the American Journal of Kidney Diseases.